Lien Van Eyck
Clinical Development Lead
Astrivax
Leuven, Belgium
2 profile visits
About me
My organisation
Astrivax
AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax is developing a first-in-class Plug & Play vaccine platform, for the development of prophylactic and therapeutic vaccines.
Additional questions
How would you categorise yourself?
ResearcherHealth care professional
Organisation Type
Biotech company/R&D
Areas of expertise
Data management, analytics and monitoringResearch and developmentVaccine R&DDiagnosticsClinical development and trialsOther
Therapeutic areas
Infectious diseases ImmunologyAutoimmune disorders Rare diseases
1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.
I agree